查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888579

全球解剖病理學市場：市場規模、佔有率和趨勢分析（按產品/服務、應用、最終用途和地區分類），細分市場預測（2025-2033 年）

Anatomic Pathology Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Consumables, Services), By Application (Disease Diagnosis, Drug Discovery And Development), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

解剖病理學市場概覽

2024年全球解剖病理學市場規模估計為347.2億美元，預計2033年將達到807.8億美元。

預計從 2025 年到 2033 年，該市場將以 9.79% 的複合年成長率成長。推動市場成長的關鍵因素包括全球癌症和慢性疾病負擔的加重、精準醫療和個人化醫療的日益普及，以及數位病理學和人工智慧 (AI) 技術的進步。

例如，2025年7月，PathAI（美國）推出了精準病理網路（PPN），這是全球首個配備該公司AISight 1影像管理系統（IMS）的數位解剖病理實驗室網路。 PPN旨在讓參與實驗室能夠儘早使用PathAI與生物製藥產業合作開發的最新人工智慧病理解決方案，從而實現真實世界病理數據的商業化，支持生物製藥公司進行循證研究，並推動利用人工智慧病理學的新型臨床開發策略。此外，人口老化和不斷成長的醫療保健需求正在推動全球解剖病理產業的成長。根據《2024年世界人口展望》，未來50至60年世界人口預計將持續成長，從2024年的82億增加到2080年代中期的約103億。

分子病理學和伴隨診斷（CDx）的進步使得疾病診斷和治療更加精準、個人化和標靶治療，顯著擴大了全球市場。分子病理學透過檢測與特定疾病（尤其是癌症）相關的基因、分子和細胞改變，實現更早期、更準確的診斷。伴隨診斷透過識別最有可能從特定治療方法中獲益的患者，指導標靶治療的應用。這種診斷與治療相結合的方法正日益應用於腫瘤學和其他醫學領域，推動了對先進病理服務的需求。隨著製藥公司持續投資於個人化醫療，監管機構也鼓勵將伴隨診斷整合到藥物研發過程中，解剖病理學的角色正從傳統的組織學擴展到分子層面，加速市場成長和創新。

除了日益加重的疾病負擔和技術進步之外，還有其他幾個因素推動著全球解剖病理學產業的發展。患者和醫療保健提供者對早期準確診斷重要性的認知和教育程度不斷提高，導致對病理診斷服務的需求增加。常規健康檢查和預防性醫療保健計劃的開展，使得切片檢查手術量增加，從而推動了病理分析的需求。此外，醫療服務模式從醫院向門診和專業診斷中心的轉變，提高了病理診斷服務的可近性和效率。已開發國家優惠的報銷政策以及新興經濟體政府為加強診斷基礎設施所採取的支持措施，也進一步推動了市場成長。

此外，診斷實驗室、醫院和科技公司之間的策略聯盟、合併和收購正在推動創新，並有助於擴大各地區的服務範圍。

目錄

第1章 解剖病理學市場：調查方法與範圍

2. 解剖病理學市場：執行摘要

  • 市場概覽
  • 產品和服務概述
  • 應用概述
  • 最終用途概述
  • 競爭格局概述

3. 解剖病理學市場：促進因素、趨勢與範圍

  • 市場區隔和範圍
  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 全球癌症和慢性疾病負擔日益加重
    • 擴大精準醫療和個人化醫療的引入
    • 數位病理學和人工智慧（AI）的進展
    • 分子病理學和伴隨診斷（CDx）的擴展
    • 老化和醫療保健的擴張
  • 市場限制因素分析
    • 先進診斷設備高成本
    • 嚴格的監管和合規要求
    • 資料隱私和網路安全問題
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章 解剖病理學市場：按產品和服務分類的估算和趨勢分析

  • 解剖病理學市場：按產品和服務分類的差異分析
  • 產品
    • 裝置
    • 消耗品
    • 服務

第5章 解剖病理學市場：按應用分類的估算與趨勢分析

  • 解剖病理學市場：按應用領域分類的差異分析
  • 疾病診斷
  • 藥物發現與開發
  • 其他

6. 解剖病理學市場：依最終用途分類的估算與趨勢分析

  • 解剖病理學市場：按最終用途分類的差異分析
  • 醫院
  • 診斷檢查室
  • 研究所
  • 其他

第7章 解剖病理學市場：按地區分類的業務分析

  • 市場概覽：按地區分類
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第8章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品發布
    • 商業夥伴關係
    • 企業收購
    • 合資
    • 資金籌措
  • 主要企業市佔率分析（2024 年）
  • 公司熱力圖分析
  • 公司簡介
    • Danaher
    • PHC Holdings Corporation
    • Quest Diagnostics Incorporated
    • Laboratory Corporation of America Holdings
    • F. Hoffmann-La Roche AG
    • Agilent Technologies, Inc.
    • Sakura Finetek USA, Inc.
    • NeoGenomics Laboratories, Inc.
    • BioGenex
    • Bio SB
Product Code: GVR-3-68038-318-8

Anatomic Pathology Market Summary

The global anatomic pathology market size was estimated at USD 34.72 billion in 2024 and is projected to reach USD 80.78 billion by 2033, growing at a CAGR of 9.79% from 2025 to 2033. Some of the major factors driving the market growth are rising global cancer and chronic disease burden, growing adoption of precision and personalized medicine, and digital pathology and artificial intelligence (AI) advancements.

For instance, in July 2025, PathAI (U.S.) launched the Precision Pathology Network (PPN), a first-of-its-kind network of digital anatomic pathology laboratories powered by PathAI's AISight 1 Image Management System (IMS). The PPN is intended to provide early access to the most recent AI-powered pathology solutions developed by PathAI in collaboration with the biopharma industry, to allow participating laboratories to monetize real-world pathology data, to support biopharma-sponsored evidence generation studies, and to enable novel clinical development strategies that leverage AI-pathology. Furthermore, an aging population and rising healthcare expenditure fuel the growth of the global anatomic pathology industry. As per the World Population Prospects 2024, the world's population is expected to keep growing for another 50 or 60 years, peaking at around 10.3 billion in the mid-2080s, up from 8.2 billion in 2024.

The growth of molecular pathology and companion diagnostics (CDx) is significantly increasing the global market by allowing for more precise, personalized, and targeted approaches to disease diagnosis and treatment. Molecular pathology detects genetic, molecular, and cellular changes associated with specific diseases, most notably cancer, allowing for earlier and more accurate diagnoses. Companion diagnostics help guide the use of targeted therapies by identifying patients who are most likely to benefit from specific treatments. This combination of diagnostics and therapeutics is increasingly being used in oncology and other fields of medicine, driving demand for advanced pathology services. As pharmaceutical companies continue to invest in personalized medicine and regulatory agencies encourage the incorporation of CDx into drug development pipelines, the role of anatomic pathology is expanding beyond traditional histology to include molecular insights, accelerating market growth and innovation.

In addition to rising disease burdens and technological advancements, a number of other factors are driving the global anatomic pathology industry. The growing awareness and education of patients and healthcare providers about the importance of early and accurate diagnosis is driving up demand for pathology services. The growing number of biopsy procedures, driven by routine health screenings and preventive care programs, is increasing the demand for pathology analysis. Furthermore, the transition from hospital-based care to outpatient and specialized diagnostic centers improves pathology services' accessibility and efficiency. Favorable reimbursement policies in developed countries, as well as supportive government initiatives to strengthen diagnostic infrastructure in emerging economies, are further driving market growth.

Furthermore, strategic collaborations, mergers, and acquisitions between diagnostic labs, hospitals, and technology companies are fostering innovation and expanding service offerings across regions.

Global Anatomic Pathology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the anatomic pathology market report based on product & service, application, end use, and region:

  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
    • Microtomes & Cryostat
    • Tissue Processors
    • Automatic Stainers
    • Whole Slide Imaging (WSI) Scanners
    • Other Products
  • Consumables
    • Reagents & Antibodies
    • Probes & Kits
    • Others
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Disease Diagnosis
  • Drug Discovery and Development
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Anatomic Pathology Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Method
      • 1.1.1.2. Application Segment
      • 1.1.1.3. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Anatomic Pathology Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product & Service Snapshot
  • 2.3. Application Snapshot
  • 2.4. End Use Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Anatomic Pathology Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising Global Cancer and Chronic Disease Burden
    • 3.4.2. Growing Adoption of Precision and Personalized Medicine
    • 3.4.3. Advancements in Digital Pathology and Artificial Intelligence (AI)
    • 3.4.4. Expansion of Molecular Pathology and Companion Diagnostics (CDx)
    • 3.4.5. Aging Population and Rising Healthcare Expenditure
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Advanced Diagnostic Equipment
    • 3.5.2. Stringent Regulatory and Compliance Requirements
    • 3.5.3. Data Privacy and Cybersecurity Issues
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Anatomic Pathology Market: Product & Service Estimates & Trend Analysis

  • 4.1. Anatomic Pathology Market: Test Method Movement Analysis
  • 4.2. Products
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.2. Microtomes & Cryostat
        • 4.2.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.3. Tissue Processors
        • 4.2.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.4. Automatic Stainers
        • 4.2.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.5. Whole Slide Imaging (WSI) Scanners
        • 4.2.2.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.2.6. Other Products
        • 4.2.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.3.2. Reagents & Antibodies
        • 4.2.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.3.3. Probes & Kits
        • 4.2.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.2.3.4. Others
        • 4.2.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Services

Chapter 5. Anatomic Pathology Market: Application Estimates & Trend Analysis

  • 5.1. Anatomic Pathology Market: Mode Movement Analysis
  • 5.2. Disease Diagnosis
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Drug Discovery and Development
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Others
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Anatomic Pathology Market: End Use Estimates & Trend Analysis

  • 6.1. Anatomic Pathology Market: Product & Service Movement Analysis
  • 6.2. Hospitals
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Diagnostic Laboratories
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Research Laboratories
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Others
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Anatomic Pathology Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Anatomic Pathology Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Anatomic Pathology Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Anatomic Pathology Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Anatomic Pathology Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Anatomic Pathology Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. Danaher
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. PHC Holdings Corporation
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Quest Diagnostics Incorporated
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Laboratory Corporation of America Holdings
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. F. Hoffmann-La Roche AG
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Agilent Technologies, Inc.
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Sakura Finetek USA, Inc.
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. NeoGenomics Laboratories, Inc.
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. BioGenex
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Bio SB
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Anatomic Pathology Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 5 Global Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 North America Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 9 North America Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 10 North America Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 12 U.S. Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 U.S. Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 15 Canada Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 Canada Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Europe Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 18 Europe Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 19 Europe Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Europe Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 UK Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 22 UK Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 UK Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 24 Germany Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 25 Germany Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 26 Germany Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 France Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 28 France Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 France Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 Italy Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 31 Italy Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 32 Italy Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 33 Spain Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 34 Spain Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 35 Spain Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 Denmark Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 37 Denmark Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 38 Denmark Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 39 Sweden Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 40 Sweden Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 Sweden Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Norway Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 43 Norway Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Norway Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 Japan Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 50 Japan Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 51 Japan Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 52 China Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 53 China Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 China Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 55 India Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 56 India Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 India Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Australia Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 59 Australia Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 60 Australia Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 61 South Korea Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 62 South Korea Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 South Korea Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 64 Thailand Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 65 Thailand Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Latin America Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 68 Latin America Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 69 Latin America Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 70 Latin America Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 Brazil Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 72 Brazil Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 Brazil Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 74 Mexico Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 75 Mexico Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 Mexico Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 78 Argentina Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Anatomic Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 81 MEA Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 82 MEA Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 84 South Africa Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 85 South Africa Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 90 UAE Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 91 UAE Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Anatomic Pathology Market, By Product & Service, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Anatomic Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Anatomic Pathology Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Anatomic Pathology Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Anatomic Pathology Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Anatomic Pathology Market driver impact
  • Fig. 14 Anatomic Pathology Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Anatomic Pathology Market: Product & Service outlook and key takeaways
  • Fig. 19 Anatomic Pathology Market: Product & Service movement analysis & market share 2024 & 2030
  • Fig. 20 Products Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Instruments Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Microtomes & Cryostat Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Automatic Stainers Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Whole Slide Imaging (WSI) Scanners Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Other Products Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Consumables Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Reagents & Antibodies Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Probes & Kits Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Others Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Services Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Anatomic Pathology Market: Product & Service outlook and key takeaways
  • Fig. 32 Anatomic Pathology Market: Product & Service movement analysis & market share 2024 & 2030
  • Fig. 33 Hospitals Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Diagnostic Laboratories Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Research Laboratories Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Others Anatomic Pathology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 Global Anatomic Pathology Market: Regional movement analysis
  • Fig. 39 U.S. Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Canada Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Europe Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 UK Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Germany Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 France Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Italy Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Spain Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Norway Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Asia-Pacific Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Japan Market Estimates and Forecast, 2021 - 2033(USD Million)
  • Fig. 53 China Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 54 India Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 55 South Korea Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Australia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Thailand Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Latin America Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Brazil Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Argentina Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 MEA Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 62 South Africa Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Saudi Arabia Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 64 UAE Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Kuwait Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Strategy framework